Glaxo Group Limited

Raquel Fernandez Menendez

Silvia Gonzalez Del Valle

Julia Castro Pichel

Esther Pilar Fernandez Velando

Alfonso Mendoza Losana

Lluis Ballell Pages

Araceli Mallo-Rubio

Matthew James Wolfendale

A compound of Formula (I) or a pharmaceutically acceptable salt thereof: Wherein: Het is a 5 to 10-membered heteroaromatic ring; Either X is N and Y is CR; or X is C and Y is S; Z is selected from N and CH; Ris selected from H and Calkyl; Ris selected from H, Calkyl, OH, &#x2014;CHOH and Calkoxy; Each Ris independently selected from OH, Calkyl, F, Cl, Br, NH, and Calkoxy; Ris selected from Calkyl and haloCalkyl; Ris selected from H, Calkyl and haloCalkyl; Rand Rare either i) each independently selected from H, Calkyl and Calkoxy; or ii) Rand Rtogether with the ring to which they are attached form a 9-membered bicyclic ring; p is 0-3; and Ris selected from H and Calkyl, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.

3-amino-pyrazole derivatives useful against tuberculosis

A compound of Formula (I) or a pharmaceutically acceptable salt thereof: Wherein: Het is a 5 to 10-membered heteroaromatic ring; Either X is N and Y is CR; or X is C and Y is S; Z is selected from N and CH; Ris selected from H and Calkyl; Ris selected from H, Calkyl, OH, &#x2014;CHOH and Calkoxy; Each Ris independently selected from OH, Calkyl, F, Cl, Br, NH, and Calkoxy; Ris selected from Calkyl and haloCalkyl; Ris selected from H, Calkyl and haloCalkyl; Rand Rare either i) each independently selected from H, Calkyl and Calkoxy; or ii) Rand Rtogether with the ring to which they are attached form a 9-membered bicylic ring; p is 0-3; and Ris selected from H and Calkyl, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.

A compound of Formula (I) wherein: either X is N and Y is CRor X is C and Y is S; Z is selected from N and CH; Ris selected from H and Me; Ris selected from H, OH, OMe and Me; each Ris independently selected from Calkyl, F, Cl, Br, CFand NH; Ris selected from Me, CF, NOand CHF; Ris selected from H, Me and CHF; Ris selected from H and Me; and p is 0-3, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided.

Growing community of inventors

Madrid, Spain

Raquel Fernandez Menendez